Lab equipment in the focus of view
Products & Prices
Page 8 from 10
Lab.ru Consulting | News | Suppliers' news | Germany
Datedescending News

Bruker AXS announces Stock repurchase program.
The company announced that its Board of Directors has authorized the repurchase of up tp 2.5 million shares of Bruker AXS common stock. The Board of Directors views Bruker AXS’ stock as undervalued in the market place and it believes that the stock repurchase program will be beneficial to Bruker AXS shareholders.


Bruker posts profit, cuts 5% of workforce
August 13, 2002
Bruker posts profit, cuts 5% of workforce
Fitchburg-based Bruker AXS Inc., which develops sophisticated X-ray systems for life and materials sciences, reported a second-quarter profit on increased sales, and a restructuring that included about 5 percent cut in its workforce.
Bruker reported second-quarter net income of $609,000, or 1 cent per diluted share, on revenues of $24 million, compared with a net loss of $1.8 million, or 4 cents per diluted share, on revenues of $20.2 million a year ago.

The cuts reduced Bruker's global workforce from about 560 to about 530, including about 100 locally, where seven positions were eliminated, CEO Martin Haase said in an interview today.
The positions cut were redundant due to Bruker's two acquisitions over the past 18 months. The cuts, streamlining production and reducing operating expenses will produce annual cost savings of $2 million to $3 million, the company said.
"This is a global program to improve our profitability," Haase said.

The company said it raised its revenue guidance for the year to a range of $99 million to $101 million, up more than 20 percent over 2001, on strong backlog, new orders and the launch of new products.


Bruker has launched a new High-Throughput Screening System for combinatorial Analysis at the Denver conference.. The system, called D8 Discover CST (comprised of a D8 Discover with GADDS for combinatorial screening in transmission) is a high-throughput X-Ray analysis tool specifically targeted at pharmaceutical and combinatorial chemistry applications, a high growth area in the analysis of advanced materials, including drug development. The D8 Discover CST was designed in response to customer demand for more efficient ways of analysing many samples at thigh speed.


S2 Ranger:
- As far as we know the S2 system is assembled in Congleton, UK
- We are not sure where the detector originates. Would like to get more input on this.
- Their 50-Watt tube comes from Varian.


It is said that the department that occupies itself with automation projects has been sold to Pfaff. Pfaff itself is now part of the FL Schmidt Automation (FLSA). As far as we know Spectro will do the acquisition but Pfaff will take over the responsibility of the project.
Rumours go that Spectro has problems with their Si(Li) detector
Roentech, A German company, has stopped delivering their products to Spectro.


Spectro announced the availability of a free of charge CD-ROM on New Technology in XRF Analysis. The IBC is interested to get a copy of this CD-ROM. Please forward the CD-ROM to Remy Denker.


Bruker participated in the EPDIC in Sweden.


Paul Friedhoff, who sold his remaining 76% share in Spectro Gesellschaft fuer Spektrometrie mbH&Ko KG in 1997, to focus on his political carreer, was seen walking the aisles at Pittcon 2202.


New Bruker organisation in Japan: Mac Science closed their Kaga Factory and moved to a new building in Tokyo. They have stopped producing all products except the rotating anode generator. Nihon Bruker ASX KK will now be called Bruker AXS KK.


Bruker AXS Announces Profitable First Quarter 2002 With 26% Revenue Increase
May 9, 2002 5:03pm
Bruker AXS Inc., (NASDAQ: BAXS), a leading global provider of advanced X-ray solutions for the life and advanced materials sciences, today reported its financial results for the first quarter 2002.
Net sales for the three months ended March 31, 2002 increased 26% to $23.8 million, compared to $18.8 million for the three months ended March 31, 2001. After elimination of unfavorable currency effects, revenue growth was 31%.
Net income for the first quarter of 2002 was $0.3 million, or $0.01 per share, compared to $0.00 per share for the first quarter of 2001.
Cash and cash equivalents totaled $53.1 million as of March 31, 2002.
Dr. Martin Haase, President and CEO, stated: "We are very pleased to announce another successful quarter of growth and operating improvements. We exceeded our expectations this quarter for both revenue growth and EBIT. "Later this year we anticipate several new product introductions targeted at the life-science market that should further contribute to our growth objectives," added Dr. Haase. "Furthermore, the recently announced acquisition of MAC Science strengthens our position in the large Japanese market, which is estimated to account for more than 25% of the world X-ray analysis market. With the integration of MAC Science's excellent compact X-ray source technology, we expect to gain market share in this very important region."
"Our healthy backlog provides good top-line visibility for the second quarter and into the third quarter of 2002," said Laura Francis, Chief Financial Officer. "In accordance with previous guidance for the year 2002, we expect robust organic revenue growth of greater than 15%, and earnings per share of $0.03, after the effects of the MAC Science acquisition."

1 2 3 4 5 6 7 8 9 10

006736 Powered by DSGroup | version 2.0 | © neoLab.ru 1998-2020